cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+

cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling Emerging chemical strategies for CD38

Name: cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling Emerging chemical strategies for CD38
Brand: creatorsinfotech.com
SKU: 59511575039
Price: 29.79 USD
Availability: InStock
Rating: 4.1548 (7 reviews)

Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect Inhibitors of NAD+ Production in Cancer Treatment: State of the Art and Perspectives PMC Selective and membrane permeable small molecule inhibitors of nicotinamide N methyltransferase reverse high fat diet induced obesity in mice PMC Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target

SKU: 59511575039 · From creatorsinfotech.com

4.2

USD29.79 USD73.79

Pay in 4 interest-free payments of $7.45 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 26 - Oct 31

Description

Esto lleva a la produccin de clulas morfolgicamente anormales o a la muerte de las clulas durante la fase de maduracin, fenmeno llamado hematopoyesis ineficiente